ArticleBMC nephrology2018

The efficacy and safety of anti-interleukin-6 receptor monoclonal blockade in a renal transplant patient with Castleman disease: early post-transplant outcome.

Masatoshi Matsunami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.